Reply to: Chronic pain assessment and management during post-treatment follow up should be considered as a high value quality indicator for specialist breast cancer center
Breast
.
2021 Dec:60:309.
doi: 10.1016/j.breast.2021.09.003.
Epub 2021 Sep 6.
Authors
Hind Mrabti
1
,
Catherine Sauvaget
2
,
Abdellatif Benider
3
,
Karima Bendahhou
3
,
Farida Selmouni
2
,
Richard Muwonge
2
,
Leila Alaoui
4
,
Eric Lucas
2
,
Youssef Chami
5
,
Patricia Villain
2
,
Loubna Abousselham
6
,
Andre L Carvalho
2
,
Maria Bennani
5
,
Hassan Errihani
1
,
Rengaswamy Sankaranarayanan
7
,
Rachid Bekkali
5
,
Partha Basu
8
Affiliations
1
Institut National d'oncologie, CHU-Rabat, Rabat, Morocco.
2
Early Detection, Prevention & Infections Branch, International Agency for Research on Cancer, Lyon, France.
3
Registre des Cancers de la R_egion du Grand Casablanca, Casablanca, Morocco.
4
National Cancer Institute, Fes, Morocco.
5
Lalla Salma Foundation, Prevention and Treatment of Cancers, Rabat, Morocco.
6
Cancer Unit, Epidemiology and Disease Control Department, Ministry of Health, Rabat, Morocco.
7
RTI International India, New Delhi, India.
8
Early Detection, Prevention & Infections Branch, International Agency for Research on Cancer, Lyon, France. Electronic address: basup@iarc.fr.
PMID:
34509362
PMCID:
PMC8714496
DOI:
10.1016/j.breast.2021.09.003
No abstract available
Publication types
Letter
Comment
MeSH terms
Breast
Breast Neoplasms* / therapy
Female
Follow-Up Studies
Humans
Pain Measurement
Quality Indicators, Health Care
Grants and funding
001/WHO_/World Health Organization/International